BioCentury
ARTICLE | Company News

Cellerix, TiGenix deal

May 9, 2011 7:00 AM UTC

Musculoskeletal company TiGenix completed its previously announced acquisition of Cellerix in a stock deal valued at €58.2 million ($86.2 million). As part of the acquisition, Eduardo Bravo, formerly ...